Concepedia

T. Ahmad

TA

Statistics

Publications

7

Citations

871

H-Index

7

Active since

2004

Affiliations

Royal Marsden Hospital(Current)

Bayer (United States)

Institute of Cancer Research

University College London

Addenbrooke's Hospital

T. Ahmad is an author at Royal Marsden Hospital specializing in oncology, medicine, and radiation oncology.

ORCID

Top concepts

Publications per year

2004–2011

7

Publications

7

Sorafenib in advanced melanoma: a Phase II randomised discontinuation trial analysis

Tim Eisen, T. Ahmad, Keith T. Flaherty et al. · British Journal of Cancer · 2006 · 633 citations · Full text

Phase I trial of BAY 43–9006 (sorafenib) combined with dacarbazine (DTIC) in metastatic melanoma patients

Tim Eisen, T. Ahmad, M. Gore et al. · Journal of Clinical Oncology · 2005 · 50 citations

, , +14

BAY 43-9006 in patients with advanced melanoma: The Royal Marsden experience

T. Ahmad, Richard Marais, L Pyle et al. · Journal of Clinical Oncology · 2004 · 48 citations

, , +17

A Novel Point Mutation in P450c17 (CYP17) Causing Combined 17α-Hydroxylase/17,20-Lyase Deficiency

Antonia Brooke, Norman Taylor, J. H. Shepherd et al. · The Journal of Clinical Endocrinology & Metabolism · 2006 · 46 citations · Full text

Sorafenib and dacarbazine as first-line therapy for advanced melanoma: phase I and open-label phase II studies

Tim Eisen, Richard Marais, Annette Affolter et al. · British Journal of Cancer · 2011 · 43 citations · Full text

1–5 of 7